Key points are not available for this paper at this time.
Figure S13. Boxplots showing usage of epithelial cNMF programs in epithelial cells of fast and slow progressors (A) post-chemotherapy (FU1) and (B) postimmunotherapy (FU2).
An et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: